TABLE 2

Clinical Data for HNSCC

Patient no.	Sex	Age (y)	Body weight (kg)	Lesion type	Location of primary tumor	¹⁸F-FDG PET indication	Staging	¹⁸F-FMT dose (MBq)	Specific activity^* (GBq/μmol)
1	M	50	58	SCC	Hypopharyngeal	Staging	T4 N2 M0	306	31.8
2	M	70	75	SCC	Laryngeal	Staging	T3 N2c M0	300	25.5
3	M	67	84	SCC	Oropharynx	Staging	T4 N3 M0	304	82.2
4	M	64	77	SCC	Tongue	Staging	T2 N2a M0	306	38.5
5	M	68	70	SCC	Oropharynx	Restaging	T3 N2 M0	318	83.9
6	M	48	113	SCC	Oropharynx	Staging	T1 N2b M0	324	57.2
7	M	44	89	SCC	Oropharynx	Staging	T4 N2c M0	303	47.4
8	M	67	83	SCC	Hypopharyngeal	Restaging	T2 N2 M0	316	38.2

↵* Specific activity at time point of injection.
SCC = squamous cell carcinoma.